The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Plasma Fractionation and Blood Product Market Research Report 2025
Synopsis
Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Plasma Fractionation.
The global Plasma Fractionation and Blood Product market was valued at US$ 4814.4 million in 2023 and is anticipated to reach US$ 5825.2 million by 2030, witnessing a CAGR of 2.8% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Plasma Fractionation and Blood Product, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Plasma Fractionation and Blood Product.
Report Scope
The Plasma Fractionation and Blood Product market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Plasma Fractionation and Blood Product market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Plasma Fractionation and Blood Product manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Segment by Type
Coagulation Factor
Immune Globulin
Albumin
Other
Segment by Application
Immunology
Hematology
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Plasma Fractionation and Blood Product manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Plasma Fractionation and Blood Product in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Plasma Fractionation.
The global Plasma Fractionation and Blood Product market was valued at US$ 4814.4 million in 2023 and is anticipated to reach US$ 5825.2 million by 2030, witnessing a CAGR of 2.8% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Plasma Fractionation and Blood Product, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Plasma Fractionation and Blood Product.
Report Scope
The Plasma Fractionation and Blood Product market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Plasma Fractionation and Blood Product market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Plasma Fractionation and Blood Product manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Segment by Type
Coagulation Factor
Immune Globulin
Albumin
Other
Segment by Application
Immunology
Hematology
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Plasma Fractionation and Blood Product manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Plasma Fractionation and Blood Product in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Plasma Fractionation and Blood Product Market Overview
1.1 Product Overview and Scope of Plasma Fractionation and Blood Product
1.2 Plasma Fractionation and Blood Product Segment by Type
1.2.1 Global Plasma Fractionation and Blood Product Market Value Comparison by Type (2024-2030)
1.2.2 Coagulation Factor
1.2.3 Immune Globulin
1.2.4 Albumin
1.2.5 Other
1.3 Plasma Fractionation and Blood Product Segment by Application
1.3.1 Global Plasma Fractionation and Blood Product Market Value by Application: (2024-2030)
1.3.2 Immunology
1.3.3 Hematology
1.3.4 Other
1.4 Global Plasma Fractionation and Blood Product Market Size Estimates and Forecasts
1.4.1 Global Plasma Fractionation and Blood Product Revenue 2019-2030
1.4.2 Global Plasma Fractionation and Blood Product Sales 2019-2030
1.4.3 Global Plasma Fractionation and Blood Product Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Plasma Fractionation and Blood Product Market Competition by Manufacturers
2.1 Global Plasma Fractionation and Blood Product Sales Market Share by Manufacturers (2019-2024)
2.2 Global Plasma Fractionation and Blood Product Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Plasma Fractionation and Blood Product Average Price by Manufacturers (2019-2024)
2.4 Global Plasma Fractionation and Blood Product Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Plasma Fractionation and Blood Product, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Plasma Fractionation and Blood Product, Product Type & Application
2.7 Plasma Fractionation and Blood Product Market Competitive Situation and Trends
2.7.1 Plasma Fractionation and Blood Product Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Plasma Fractionation and Blood Product Players Market Share by Revenue
2.7.3 Global Plasma Fractionation and Blood Product Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Plasma Fractionation and Blood Product Retrospective Market Scenario by Region
3.1 Global Plasma Fractionation and Blood Product Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Plasma Fractionation and Blood Product Global Plasma Fractionation and Blood Product Sales by Region: 2019-2030
3.2.1 Global Plasma Fractionation and Blood Product Sales by Region: 2019-2024
3.2.2 Global Plasma Fractionation and Blood Product Sales by Region: 2025-2030
3.3 Global Plasma Fractionation and Blood Product Global Plasma Fractionation and Blood Product Revenue by Region: 2019-2030
3.3.1 Global Plasma Fractionation and Blood Product Revenue by Region: 2019-2024
3.3.2 Global Plasma Fractionation and Blood Product Revenue by Region: 2025-2030
3.4 North America Plasma Fractionation and Blood Product Market Facts & Figures by Country
3.4.1 North America Plasma Fractionation and Blood Product Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Plasma Fractionation and Blood Product Sales by Country (2019-2030)
3.4.3 North America Plasma Fractionation and Blood Product Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Plasma Fractionation and Blood Product Market Facts & Figures by Country
3.5.1 Europe Plasma Fractionation and Blood Product Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Plasma Fractionation and Blood Product Sales by Country (2019-2030)
3.5.3 Europe Plasma Fractionation and Blood Product Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Plasma Fractionation and Blood Product Market Facts & Figures by Country
3.6.1 Asia Pacific Plasma Fractionation and Blood Product Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Plasma Fractionation and Blood Product Sales by Country (2019-2030)
3.6.3 Asia Pacific Plasma Fractionation and Blood Product Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Plasma Fractionation and Blood Product Market Facts & Figures by Country
3.7.1 Latin America Plasma Fractionation and Blood Product Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Plasma Fractionation and Blood Product Sales by Country (2019-2030)
3.7.3 Latin America Plasma Fractionation and Blood Product Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Plasma Fractionation and Blood Product Market Facts & Figures by Country
3.8.1 Middle East and Africa Plasma Fractionation and Blood Product Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Plasma Fractionation and Blood Product Sales by Country (2019-2030)
3.8.3 Middle East and Africa Plasma Fractionation and Blood Product Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Plasma Fractionation and Blood Product Sales by Type (2019-2030)
4.1.1 Global Plasma Fractionation and Blood Product Sales by Type (2019-2024)
4.1.2 Global Plasma Fractionation and Blood Product Sales by Type (2025-2030)
4.1.3 Global Plasma Fractionation and Blood Product Sales Market Share by Type (2019-2030)
4.2 Global Plasma Fractionation and Blood Product Revenue by Type (2019-2030)
4.2.1 Global Plasma Fractionation and Blood Product Revenue by Type (2019-2024)
4.2.2 Global Plasma Fractionation and Blood Product Revenue by Type (2025-2030)
4.2.3 Global Plasma Fractionation and Blood Product Revenue Market Share by Type (2019-2030)
4.3 Global Plasma Fractionation and Blood Product Price by Type (2019-2030)
5 Segment by Application
5.1 Global Plasma Fractionation and Blood Product Sales by Application (2019-2030)
5.1.1 Global Plasma Fractionation and Blood Product Sales by Application (2019-2024)
5.1.2 Global Plasma Fractionation and Blood Product Sales by Application (2025-2030)
5.1.3 Global Plasma Fractionation and Blood Product Sales Market Share by Application (2019-2030)
5.2 Global Plasma Fractionation and Blood Product Revenue by Application (2019-2030)
5.2.1 Global Plasma Fractionation and Blood Product Revenue by Application (2019-2024)
5.2.2 Global Plasma Fractionation and Blood Product Revenue by Application (2025-2030)
5.2.3 Global Plasma Fractionation and Blood Product Revenue Market Share by Application (2019-2030)
5.3 Global Plasma Fractionation and Blood Product Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Takeda
6.1.1 Takeda Corporation Information
6.1.2 Takeda Description and Business Overview
6.1.3 Takeda Plasma Fractionation and Blood Product Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Takeda Plasma Fractionation and Blood Product Product Portfolio
6.1.5 Takeda Recent Developments/Updates
6.2 CSL
6.2.1 CSL Corporation Information
6.2.2 CSL Description and Business Overview
6.2.3 CSL Plasma Fractionation and Blood Product Sales, Revenue and Gross Margin (2019-2024)
6.2.4 CSL Plasma Fractionation and Blood Product Product Portfolio
6.2.5 CSL Recent Developments/Updates
6.3 Grifols
6.3.1 Grifols Corporation Information
6.3.2 Grifols Description and Business Overview
6.3.3 Grifols Plasma Fractionation and Blood Product Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Grifols Plasma Fractionation and Blood Product Product Portfolio
6.3.5 Grifols Recent Developments/Updates
6.4 Octapharma
6.4.1 Octapharma Corporation Information
6.4.2 Octapharma Description and Business Overview
6.4.3 Octapharma Plasma Fractionation and Blood Product Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Octapharma Plasma Fractionation and Blood Product Product Portfolio
6.4.5 Octapharma Recent Developments/Updates
6.5 Kedrion
6.5.1 Kedrion Corporation Information
6.5.2 Kedrion Description and Business Overview
6.5.3 Kedrion Plasma Fractionation and Blood Product Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Kedrion Plasma Fractionation and Blood Product Product Portfolio
6.5.5 Kedrion Recent Developments/Updates
6.6 LFB Group
6.6.1 LFB Group Corporation Information
6.6.2 LFB Group Description and Business Overview
6.6.3 LFB Group Plasma Fractionation and Blood Product Sales, Revenue and Gross Margin (2019-2024)
6.6.4 LFB Group Plasma Fractionation and Blood Product Product Portfolio
6.6.5 LFB Group Recent Developments/Updates
6.7 Biotest
6.6.1 Biotest Corporation Information
6.6.2 Biotest Description and Business Overview
6.6.3 Biotest Plasma Fractionation and Blood Product Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Biotest Plasma Fractionation and Blood Product Product Portfolio
6.7.5 Biotest Recent Developments/Updates
6.8 BPL
6.8.1 BPL Corporation Information
6.8.2 BPL Description and Business Overview
6.8.3 BPL Plasma Fractionation and Blood Product Sales, Revenue and Gross Margin (2019-2024)
6.8.4 BPL Plasma Fractionation and Blood Product Product Portfolio
6.8.5 BPL Recent Developments/Updates
6.9 RAAS
6.9.1 RAAS Corporation Information
6.9.2 RAAS Description and Business Overview
6.9.3 RAAS Plasma Fractionation and Blood Product Sales, Revenue and Gross Margin (2019-2024)
6.9.4 RAAS Plasma Fractionation and Blood Product Product Portfolio
6.9.5 RAAS Recent Developments/Updates
6.10 CBPO
6.10.1 CBPO Corporation Information
6.10.2 CBPO Description and Business Overview
6.10.3 CBPO Plasma Fractionation and Blood Product Sales, Revenue and Gross Margin (2019-2024)
6.10.4 CBPO Plasma Fractionation and Blood Product Product Portfolio
6.10.5 CBPO Recent Developments/Updates
6.11 Hualan Bio
6.11.1 Hualan Bio Corporation Information
6.11.2 Hualan Bio Plasma Fractionation and Blood Product Description and Business Overview
6.11.3 Hualan Bio Plasma Fractionation and Blood Product Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Hualan Bio Plasma Fractionation and Blood Product Product Portfolio
6.11.5 Hualan Bio Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Plasma Fractionation and Blood Product Industry Chain Analysis
7.2 Plasma Fractionation and Blood Product Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Plasma Fractionation and Blood Product Production Mode & Process
7.4 Plasma Fractionation and Blood Product Sales and Marketing
7.4.1 Plasma Fractionation and Blood Product Sales Channels
7.4.2 Plasma Fractionation and Blood Product Distributors
7.5 Plasma Fractionation and Blood Product Customers
8 Plasma Fractionation and Blood Product Market Dynamics
8.1 Plasma Fractionation and Blood Product Industry Trends
8.2 Plasma Fractionation and Blood Product Market Drivers
8.3 Plasma Fractionation and Blood Product Market Challenges
8.4 Plasma Fractionation and Blood Product Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
